Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
The primary objective is to estimate ht incidence of OM in H&N cancer patients undergoing radiation therapy with or without chemotherapy and/or sensitizer who receive Caphosol.
15 weeks
No
Andy M Trotti, MD
Principal Investigator
Moffitt Cancer Center, Tampa Florida
United States: Institutional Review Board
603EUSA03
NCT00901732
May 2009
November 2010
Name | Location |
---|---|
MD Anderson Cancer Center | Houston, Texas 77030-4096 |
Beth Israel Medical Center | New York, New York 10003 |
Temple University Hospital | Philadelphia, Pennsylvania 19140 |
Duke University Medical Center | Durham, North Carolina 27710 |
H. Lee Moffitt Cancer Center | Tampa, Florida 33612 |
University of Florida College of Medicine | Gainesville, Florida 32610 |